| In millions, except per share items | Mar-31-23 | Mar-31-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 | Mar-31-16 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Patient Management Services | | | | | 368.2 | 316.6 | | |
| Network Solutions Services | | | | | 227.5 | 241.8 | | |
| Total revenues | 718.6 | 646.2 | 552.6 | 592.2 | 595.7 | 558.4 | 518.7 | 503.6 |
| Revenue growth [+] | 11.2% | 16.9% | -6.7% | -0.6% | 6.7% | 7.6% | 3.0% | 2.2% |
| Patient Management Services | | | | | 16.3% | | | |
| Network Solutions Services | | | | | -5.9% | | | |
| Cost of goods sold | 560.3 | 494.1 | 429.0 | 466.3 | 470.9 | 451.1 | 413.9 | 399.0 |
| Gross profit | 158.3 | 152.1 | 123.6 | 125.9 | 124.8 | 107.3 | 104.8 | 104.5 |
| Gross margin | 22.0% | 23.5% | 22.4% | 21.3% | 21.0% | 19.2% | 20.2% | 20.8% |
| Selling, general and administrative [+] | | | | | 63.3 | 59.4 | 57.2 | 58.5 |
| General and administrative | 0.0 | 0.0 | 0.0 | 0.0 | 63.3 | 59.4 | 57.2 | 58.5 |
| EBITDA [+] | 183.4 | 176.0 | 147.1 | 148.4 | 84.5 | 69.7 | 68.5 | 66.0 |
| EBITDA growth | 4.2% | 19.7% | -0.9% | 75.7% | 21.3% | 1.7% | 3.8% | 3.9% |
| EBITDA margin | 25.5% | 27.2% | 26.6% | 25.1% | 14.2% | 12.5% | 13.2% | 13.1% |
| Depreciation | 24.7 | 23.5 | 23.4 | 22.5 | 23.0 | 21.8 | 20.9 | 20.0 |
| EBITA | 158.7 | 152.5 | 123.6 | 125.9 | 61.5 | 47.9 | 47.5 | 46.1 |
| EBITA margin | 22.1% | 23.6% | 22.4% | 21.3% | 10.3% | 8.6% | 9.2% | 9.1% |
| Amortization of intangibles | 0.4 | 0.4 | | | | | | |
| EBIT [+] | 158.3 | 152.1 | 123.6 | 125.9 | 61.5 | 47.9 | 47.5 | 46.1 |
| EBIT growth | 4.0% | 23.0% | -1.8% | 104.7% | 28.4% | 0.7% | 3.2% | 1.1% |
| EBIT margin | 22.0% | 23.5% | 22.4% | 21.3% | 10.3% | 8.6% | 9.2% | 9.1% |
| Other income (expense), net | -73.7 | -67.6 | -64.4 | -65.2 | | | | |
| Pre-tax income | 84.6 | 84.5 | 59.2 | 60.7 | 61.5 | 47.9 | 47.5 | 46.1 |
| Income taxes | 18.2 | 18.1 | 12.8 | 13.3 | 14.8 | 12.2 | 18.1 | 17.5 |
| Tax rate | 21.5% | 21.4% | 21.7% | 22.0% | 24.1% | 25.5% | 38.0% | 38.1% |
| Net income | 66.4 | 66.4 | 46.4 | 47.4 | 46.7 | 35.7 | 29.5 | 28.5 |
| Net margin | 9.2% | 10.3% | 8.4% | 8.0% | 7.8% | 6.4% | 5.7% | 5.7% |
| |
| Basic EPS [+] | $3.83 | $3.74 | $2.59 | $2.59 | $2.48 | $1.90 | $1.52 | $1.44 |
| Growth | 2.4% | 44.7% | 0.0% | 4.0% | 31.1% | 24.9% | 5.5% | 4.0% |
| Diluted EPS [+] | $3.77 | $3.66 | $2.55 | $2.55 | $2.46 | $1.87 | $1.51 | $1.43 |
| Growth | 3.0% | 43.6% | 0.2% | 3.7% | 31.1% | 24.4% | 5.6% | 4.2% |
| |
| Shares outstanding (basic) [+] | 17.3 | 17.8 | 17.9 | 18.3 | 18.8 | 18.8 | 19.4 | 19.8 |
| Growth | -2.4% | -1.0% | -2.2% | -2.5% | -0.2% | -3.1% | -2.1% | -4.1% |
| Shares outstanding (diluted) [+] | 17.6 | 18.1 | 18.2 | 18.6 | 19.0 | 19.0 | 19.6 | 20.0 |
| Growth | -3.0% | -0.2% | -2.3% | -2.1% | -0.2% | -2.7% | -2.2% | -4.2% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |